FrancophonIA/ELRC3.0 huggingface dataset:
English: In the study looking at Prezista with cobicistat, around 81% (253 out of 313) of patients had viral loads below 50 copies/ml after 48 weeks.
Slovenian: V študiji, ki je proučevala kombinacijo zdravila Prezista in kobicistata, je imelo po 48 tednih 81 % (253 od 313) bolnikov virusno breme pod 50 kopijami/ml.
English: One study compared ritonavir-boosted Prezista 800 mg once a day with ritonavir-boosted lopinavir (another protease inhibitor) in 691 adults who had not been treated for HIV before.
Slovenian: V eni študiji so pri 691 odraslih, ki predhodno niso bili zdravljeni zaradi okužbe z virusom HIV, z ritonavirjem spodbujeno zdravilo Prezista v odmerku 800 mg enkrat na dan primerjali z lopinavirjem (drugim zaviralcem proteaze), spodbujenim z ritonavirjem.
English: EU/1/11/736/001 EDURANT
Slovenian: EU/1/11/736/001
English: (Invented) name Strength Pharmaceutical Form Route of Administration
Slovenian: Izmišljeno ime Jakost Farmacevtska oblika
English: Oral use bottle (HDPE) 30 tablets
Slovenian: 25 mg filmsko obložena tableta peroralna uporaba plastenka (HDPE)
English: 25 mg
Slovenian: 30 tablet
English: Film-coated tablet
Slovenian: Pot uporabe Ovojnina
English: This summary was last updated in 05-2014.
Slovenian: Povzetek je bil nazadnje posodobljen 05-2014.
English: This can result in loss of vision and even blindness.
Slovenian: To lahko povzroči izgubo vida in celo slepoto.
English: Azopt brinzolamide
Slovenian: Azopt brinzolamid
English: The European Commission granted a marketing authorisation valid throughout the European Union for Azopt on 9 March 2000.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Azopt, veljavno po vsej Evropski uniji, izdala 9. marca 2000.
English: What measures are being taken to ensure the safe and effective use of Azopt?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Azopt?
English: Other information about Azopt
Slovenian: Druge informacije o zdravilu Azopt
English: The full EPAR for Azopt can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Azopt je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: What benefit has Azopt shown during the studies?
Slovenian: Kakšne koristi je zdravilo Azopt izkazalo med študijami?
English: This is a summary of the European public assessment report (EPAR) for Azopt.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Azopt.
English: A risk management plan has been developed to ensure that Azopt is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Azopt je bil pripravljen načrt obvladovanja tveganj.
English: In all of the studies, the main measure of effectiveness was the change in pressure inside the eye, measured in units called ‘millimetres of mercury' (mmHg).
Slovenian: V vseh študijah je bilo glavno merilo učinkovitosti sprememba tlaka v očesu, ki se meri v enotah, imenovanih „milimetri živega srebra“ (mmHg).
English: What is the risk associated with Azopt?
Slovenian: Kakšna tveganja so povezana z zdravilom Azopt?
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Azopt's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Azopt večje od z njim povezanih tveganj, in priporočil, da se zanj izda dovoljenje za promet.
English: For more information about treatment with Azopt, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Azopt preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: It must not be used in patients with severe kidney disease or hyperchloraemic acidosis (excess acid in the blood caused by too much chloride).
Slovenian: Ne smejo ga uporabljati bolniki s hudim obolenjem ledvic ali hiperkloremično acidozo (preveč kisline v krvi, ki jo povzroča preveč klorida).
English: The eye pressure was at least 21 mmHg in all of the patients at the start of the studies (above the normal range of 10 to 21 mmHg).
Slovenian: Očesni tlak je pri vseh bolnikih na začetku študij znašal vsaj 21 mmHg (kar je nad običajno vrednostjo, ki je od 10 do 21 mmHg.
English: Azopt has been studied in seven main studies including a total of 2,173 patients with open-angle glaucoma or ocular hypertension.
Slovenian: Zdravilo Azopt so raziskali v sedmih glavnih študijah z 2 173 bolniki z glavkomom odprtega zakotja ali očesno hipertenzijo.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Azopt, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Azopt in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: If more than one type of eye-drop medicine is being used, each one should be given at least five minutes apart.
Slovenian: Če bolnik uporablja več vrst kapljic za oko, je treba zdravila dajati v razmiku najmanj pet minut.
English: Dorzolamide led to decreases of between 4.3 and 4.9 mmHg.
Slovenian: Dorzolamid je povzročil znižanje tlaka od 4,3 do 4,9 mmHg.
English: All of the studies lasted for three months, except for the study comparing Azopt used on its own with timolol, which lasted for 18 months.
Slovenian: Vse študije so trajale tri mesece, razen študije, v kateri so primerjali učinek samostojnega zdravila Azopt s timololom, ki je trajala 18 mesecev.
English: However, the results suggested that some patients may show a greater reduction in eye pressure when using the drops three times a day.
Slovenian: Vendar so rezultati pokazali, da se je pri nekaterih bolnikih tlak v očesu znižal bolj, če so kapljice jemali trikrat na dan.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Azopt.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Azopt, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: By lowering the pressure, Azopt reduces the risk of damage to these structures.
Slovenian: Zdravilo Azopt z zniževanjem tlaka zmanjša nevarnost poškodb teh struktur.
English: It is used in patients with ocular hypertension (when the pressure in the eye is higher than normal) or open-angle glaucoma (a disease in which the pressure inside the eye rises because fluid cannot drain out of the eye).
Slovenian: Uporablja se pri bolnikih z okularno hipertenzijo (kadar je tlak v očesu višji od običajnega) ali glavkomom odprtega zakotja (boleznijo, pri kateri se tlak v očesu zviša, ker tekočina ne more iztekati iz očesa).
English: In both studies, adding either Azopt or timolol caused a further decrease in eye pressure of around 3.5 mmHg after 12 weeks.
Slovenian: V obeh študijah je dodatek zdravila Azopt ali timolola povzročil dodatno znižanje tlaka v očesu za približno 3,5 mmHg po 12 tednih.
English: Azopt is used to reduce the pressure inside the eye.
Slovenian: Zdravilo Azopt se uporablja za zniževanje tlaka v očesu.
English: Azopt must not be used in people who are hypersensitive (allergic) to brinzolamide or any of the other ingredients, or to other medicines called sulphonamides (such as some antibiotics).
Slovenian: Zdravila Azopt ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) brinzolamid ali katero koli drugo sestavino zdravila ali druga zdravila, imenovana sulfonamidi (kot so nekateri antibiotiki).
English: Overall, Azopt showed a similar effect when used two or three times a day.
Slovenian: Zdravilo Azopt je izkazalo podoben učinek, kadar so ga bolniki jemali dvakrat ali trikrat dnevno.
English: Bicarbonate is required for the production of the aqueous humour (the watery fluid in the eye).
Slovenian: Bikarbonat je potreben za proizvodnjo prekatne vodke (vodene tekočine v očesu).
English: Raised pressure inside the eye causes damage to the retina (the light-sensitive surface at the back of the eye) and to the optic nerve (the nerve that sends signals from the eye to the brain).
Slovenian: Zvišan tlak znotraj očesa poškoduje mrežnico (površino na zadnji strani zrkla, ki je občutljiva za svetlobo) in vidni živec (živec, ki pošilja signale iz očesa v možgane).
English: It is available as an eye drop suspension.
Slovenian: Na voljo je kot suspenzija v obliki kapljic za oko.
English: By blocking the production of bicarbonate in the eye, Azopt slows down the production of aqueous humour, reducing the pressure inside the eye.
Slovenian: Z zaviranjem proizvodnje bikarbonata v očesu zdravilo Azopt upočasni proizvodnjo prekatne vodke in tako zniža tlak v očesu.
English: Why has Azopt been approved?
Slovenian: Zakaj je bilo zdravilo Azopt odobreno?
English: It works by blocking an enzyme called carbonic anhydrase, which produces bicarbonate in the body.
Slovenian: Deluje tako, da zavira karboanahidrazo, encim, ki v telesu proizvaja bikarbonat.
English: When used on its own, Azopt was less effective than timolol.
Slovenian: Zdravilo Azopt, uporabljeno samostojno, je bilo manj učinkovito kot timolol.
English: Azopt caused a reduction in eye pressure of between 2.7 and 5.7 mmHg over 18 months, compared with a reduction of between 5.2 and 6.0 mmHg with timolol.
Slovenian: Zdravilo Azopt je v 18 mesecih povzročilo znižanje tlaka v očesu od 2,7 do 5,7 mmHg, timolol pa od 5,2 do 6,0 mmHg.
English: Azopt is used as an add-on to beta blockers or prostaglandin analogues (other medicines used for these conditions), or on its own in patients who cannot take or do not respond to beta blockers.
Slovenian: Zdravilo Azopt se uporablja kot dodatek zaviralcem beta receptorjev ali prostaglandinskim analogom (drugima zdraviloma za ti dve bolezni) ali samostojno pri bolnikih, ki ne prenašajo zaviralcev beta receptorjev ali se nanje ne odzivajo.
English: Two of the studies compared adding Azopt, dorzolamide or placebo (a dummy treatment) to timolol, and the final two studies compared Azopt used twice a day with timolol, when they were used as an add-on to travoprost (a prostaglandin analogue).
Slovenian: V dveh študijah so primerjali zdravilo Azopt, dorzolamid ali placebo (zdravilo brez zdravilne učinkovine) kot dodatek timololu, v zadnjih dveh študijah pa so primerjali zdravilo Azopt, ki so ga bolniki jemali dvakrat na dan, s timololom, kadar sta bila oba uporabljena kot dodatek travoprostu (prostaglandinskemu analogu).
English: Azopt is a medicine that contains the active substance brinzolamide.
Slovenian: Azopt je zdravilo, ki vsebuje zdravilno učinkovino brimzolamid.
English: The active substance in Azopt, brinzolamide, is a carbonic anhydrase inhibitor.
Slovenian: Zdravilna učinkovina zdravila Azopt, brinzolamid, je zaviralec karboanahidraze.
English: In three of the studies, Azopt, used on its own two or three times a day, was compared with timolol (a beta-blocker) and with dorzolamide (another carbonic anhydrase inhibitor).
Slovenian: V treh študijah so zdravilo Azopt, ki so ga bolniki jemali samostojno z dvema ali tremi odmerki na dan, primerjali s timololom (zaviralcem beta receptorjev) in dorzolamidom (drugim zaviralcem karboanahidraze).
English: Azopt was as effective as dorzolamide when used on its own or as an add-on to timolol, with decreases in pressure of between 3.4 and 5.7 mmHg.
Slovenian: Zdravilo Azopt je bilo samostojno ali v kombinaciji s timololom enako učinkovito kot dorzolamid; tlak v očesu se je znižal od 3,4 do 5,7 mmHg.
English: Azopt was also more effective than placebo when used as an add-on to timolol.
Slovenian: Zdravilo Azopt je bilo kot dodatek timololu učinkovitejše tudi od placeba.
English: The most common side effects with Azopt (seen in more than 1 patient in 20) are dysgeusia (a bitter or unusual taste in the mouth) and temporary blurring of vision.
Slovenian: Najpogostejša neželena učinka zdravila Azopt (opažena pri več kot 1 bolniku od 20) sta disgevzija (trpek ali nenavaden okus v ustih) in začasno zamegljen vid. Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Azopt, glejte navodilo za uporabo.
English: What is Azopt?
Slovenian: Kaj je zdravilo Azopt?
English: How has Azopt been studied?
Slovenian: Kako je bilo zdravilo Azopt raziskano?
English: When used as an add-on to travoprost, Azopt had a similar effect to timolol in reducing eye pressure.
Slovenian: Kot dodatek travoprostu je imelo zdravilo Azopt pri zniževanju tlaka v očesu podoben učinek kot timolol.
English: What is Azopt used for?
Slovenian: Za kaj se zdravilo Azopt uporablja?
English: How is Azopt used?
Slovenian: Kako se zdravilo Azopt uporablja?
English: The dose of Azopt is one drop into the affected eye(s) twice a day.
Slovenian: Odmerek zdravila Azopt je ena kapljica v prizadeto oko/prizadeti očesi dvakrat na dan. Nekateri bolniki se bolje odzivajo na odmerek ene kapljice trikrat na dan. Suspenzijo je treba pred uporabo pretresti.
English: How does Azopt work?
Slovenian: Kako zdravilo Azopt deluje?
English: - if you are over 65.
Slovenian: - če ste starejši od 65 let.
English: ** based on historical comparison.
Slovenian: ** Na osnovi predhodnih primerjav.
English: As of week 144:
Slovenian: 144. teden:
English: (mechanism)
Slovenian: (mehanizem)
English: *lower than recommended dose
Slovenian: * nižji od priporočenih odmerkov
English: in the evening without efavirenz.
Slovenian: zvečer brez efavirenza.
English: See leaflet for further information.
Slovenian: Glejte navodilo za nadaljnje informacije.
English: This is very important because the amount of virus may start to increase if the medicine is stopped for even a short time.
Slovenian: To je zelo pomembno, saj se količina virusa lahko začne večati, tudi če zdravilo prenehate jemati samo za kratek čas.
English: - if any member of your family (parents, grandparents, brothers or sisters) has died suddenly due to a heart problem or was born with heart problems.
Slovenian: če je kateri koli član vaše družine (starši, stari starši, bratje ali sestre) nenadoma umrl zaradi težav s srcem ali je bil rojen s težavami srca,
English: Interaction studies with these agents have only been performed in adults.
Slovenian: Študije medsebojnega delovanja teh učinkovin so opravili samo pri odraslih.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu
Slovenian: Podrobne informacije o tem zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu.
English: Keep the tablet bottle with you so that you can easily describe what you have taken.
Slovenian: Plastenko s tabletami imejte pri sebi, da lahko hitro razložite, kaj ste vzeli.
English: Tell your doctor immediately if you are pregnant or intend to become pregnant.
Slovenian: Takoj povejte zdravniku, če ste noseči ali načrtujete zanositev.
English: Values for Test and Reference are mean (% coefficient of variation).
Slovenian: Vrednosti za test in referenco so srednje vrednosti (odstotek koeficienta variabilnosti).
English: Any inflammatory symptoms should be evaluated and treatment instituted when necessary.
Slovenian: Kakršne koli vnetne simptome je treba oceniti in po potrebi uvesti zdravljenje.
English: Tenofovir concentrations not measured, no effect is expected.
Slovenian: Koncentracij tenofovirja niso merili, učinki niso pričakovani.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c (7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Slovenian: Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
English: The incidence of erythema multiforme or Stevens-Johnson syndrome was approximately 0.1%.
Slovenian: Pojavnost multiformnega eritema ali Stevens-Johnsonovega sindroma je bila približno 0,1-odstotna.
English: This decrease in atazanavir Cmin might negatively impact the efficacy of atazanavir.
Slovenian: To zmanjšanje atazanavirja Cmin lahko negativno vpliva na učinkovitost atazanavirja.
English: Table 3: Development of resistance in study GS-01-934 through week 144
Slovenian: Tabela 3: Razvoj odpornosti v študiji GS-01-934 do 144. tedna
English: Use within 60 days after first opening.
Slovenian: Porabite v 60 dneh po odprtju.
English: Similar results were found by other investigators, although the MPA plasma levels were more variable in the second study.
Slovenian: Do podobnih rezultatov so prišli tudi drugi raziskovalci, čeprav so bile koncentracije MPA v plazmi v drugi študiji bolj spremenljive.
English: - if you have severe liver disease.
Slovenian: - če imate hudo jetrno bolezen,
English: Tell your doctor immediately about new or unusual symptoms after you stop treatment, particularly symptoms you associate with hepatitis B infection.
Slovenian: Zdravnika takoj obvestite o kakršnih koli novih ali nenavadnih simptomih po prenehanju zdravljenja, zlasti o simptomih, ki jih povezujete z okužbo z virusom hepatitisa B.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 05 September 2017
Slovenian: Datum prve odobritve: 05 September 2017
English: HORMONAL CONTRACEPTIVES Oral:
Slovenian: HORMONSKA KONTRACEPCIJSKA SREDSTVA Peroralno:
English: You can also report side effects directly via the national reporting system listed in Appendix V By reporting side effects you can help provide more information on the safety of this medicine.
Slovenian: O neželenih učinkih lahko poročate tudi neposredno na nacionalni center za poročanje, ki je naveden v Prilogi V. S tem, ko poročate o neželenih učinkih, lahko prispevate k zagotovitvi več informacij o varnosti tega zdravila.
English: Based on the different elimination pathways, no interaction is expected.
Slovenian: Glede na različne poti izločanja medsebojno delovanje ni pričakovano.
English: *lower than recommended doses; similar findings are expected with recommended doses.
Slovenian: * nižji od priporočenih odmerkov, podobno se pričakuje pri priporočenih odmerkih.
English: - if you have or have had kidney disease, or if tests have shown problems with your kidneys.
Slovenian: - če imate ali ste imeli bolezen ledvic ali če so testi pokazali, da imate bolezni ledvic.
English: [To appear on outer carton only]
Slovenian: [Navesti samo na zunanji ovojnini]
English: Write the date the bottle was opened on the label and/or carton in the space provided.
Slovenian: Napišite datum odprtja plastenke na nalepko in/ali škatlo, v za to predviden prostor.
English: - if you have a history of mental illness, including depression, or of substance or alcohol abuse.
Slovenian: - če ste kdaj imeli duševne bolezni, vključno z depresijo ali zlorabo alkohola in drugih substanc.
English: Antibiotics
Slovenian: Antibiotiki
English: Mean percent change in AUC, Cmax, Cmin with 90% confidence intervals if available
Slovenian: Povprečna sprememba odstotka pričakovane izpostavljenosti (AUC), Cmax, Cmin z 90-odstotnimi intervali zaupanja, če so na voljo
English: The incidence of neural tube defects in the general population ranges from 0.5-1 case per 1,000 live births.
Slovenian: Pojavnost okvar nevralne cevi pri prebivalstvu na splošno je od 0,5 do 1 primera na 1000 živorojenih otrok.
English: It is important to tell your doctor or pharmacist if you are taking any of the following:
Slovenian: Pomembno je, da zdravniku ali farmacevtu poveste, če jemljete katero koli izmed naslednjih zdravil:
English: Do not use this medicine after the expiry date which is stated on the bottle and carton after ‘EXP'.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na plastenki in škatli poleg oznake „EXP“.
English: Substitutions at RT positions 98, 100, 101, 108, 138, 188, 190 or 225 were also observed, but at lower frequencies, and often only in combination with K103N.
Slovenian: Opazili so tudi substitucije pri RT na položajih 98, 100, 101, 108, 138, 188, 190 ali 225, vendar redkeje in pogosto le v kombinaciji s K103N.
English: Lopinavir concentrations: ↓ 30
Slovenian: Koncentracije lopinavirja: ↓ 30
English: Open date:
Slovenian: Datum odprtja:
English: Tell your doctor if you are taking other medicines which may damage your kidneys.
Slovenian: Obvestite zdravnika, če jemljete druga zdravila, ki lahko škodijo ledvicam.
English: <for carton only> Open date:
Slovenian: <samo za škatlo> Datum odprtja:
English: - if you have a history of liver disease, including chronic active hepatitis.
Slovenian: - če ste v preteklosti imeli bolezen jeter, vključno s kroničnim aktivnim hepatitisom.
English: A risk to the infants cannot be excluded.
Slovenian: Tveganja za dojenega novorojenčka/otroka ne moremo izključiti.
English: Frequencies are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100) or rare (≥ 1/10,000 to < 1/1,000).
Slovenian: Pogostnost je opredeljena kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100) ali redki (≥ 1/10.000 do < 1/1.000).
English: No effect (↔) equals a decrease in mean ratio estimate of ≤ 20% or increase in mean ratio estimate of ≤ 25%.
Slovenian: Brez učinka (↔) je enako zmanjšanju ocene razmerja srednje vrednosti ≤ 20 % ali zvišanju ocene razmerja srednje vrednosti ≤ 25 %.
English: See ritonavir row below.
Slovenian: Glejte vrstico o ritonavirju spodaj.
English: - any signs of skin rash.
Slovenian: - kakršne koli znake kožnega izpuščaja.
English: These metabolites are essentially inactive against HIV-1.
Slovenian: Ti presnovki so večinoma neaktivni proti virusu HIV1.
English: Confirmatory testing by a more specific method such as gas chromatography/mass spectrometry is recommended in such cases.
Slovenian: V teh primerih je priporočeno izvesti potrjevalne preskuse z bolj specifično metodo, kot je plinska kromatografija/masna spektrometrija.
English: Some patients accidentally taking 600 mg efavirenz twice daily have reported increased nervous system symptoms.
Slovenian: Nekateri bolniki, ki so pomotoma vzeli 600 mg efavirenza dvakrat na dan, so poročali o povečanju simptomov živčevja.
English: Efavirenz is an NNRTI of HIV-1.
Slovenian: Efavirenz je NNRTI za HIV-1.
English: hepatic steatosis, hepatitis
Slovenian: jetrna steatoza, hepatitis
English: Interaction not studied.
Slovenian: Medsebojnega delovanja niso preučevali.
English: These tumours are unlikely to be of relevance to humans.
Slovenian: Ni verjetno, da bi bili ti tumorji pomembni za človeka.
English: - Lactic acidosis (excess lactic acid in the blood) is a rare (may affect up to 1 in every 1,000 patients) but serious side effect that can be fatal.
Slovenian: - Laktacidoza (čezmerna količina mlečne kisline v krvi) je redek (pojavi se lahko pri največ 1 od 1.000 bolnikov), vendar resen neželeni učinek, ki je lahko smrten.
English: - anorexia
Slovenian: - anoreksija
English: Patients should be instructed that if they experience these symptoms they should avoid potentially hazardous tasks such as driving and operating machinery.
Slovenian: Bolnike je treba poučiti, naj se v primeru teh simptomov izogibajo potencialno nevarnim opravilom, kakršna sta vožnja ali upravljanje strojev.
English: Expected: Voxilaprevir:↓
Slovenian: Pričakovano: voksilaprevir:↓